difference between dulaglutide and semaglutide vs. for glycemic weight control in patients with type 2 diabetes mellitus: A systematic review and meta‑analysis Dulaglutide vs Semaglutide | A

It is about biochemistry

Epub 2022 Jul 15

In patients with type 2 diabetes mellitus, treatment with semaglutide injection 1 mg resulted in reductions in glucose in terms of absolute change from baseline and relative reduction compared to placebo of 29 mg/dL (22%) for fasting glucose, 74 mg/dL (36%) for 2-hour postprandial glucose and 30 mg/dL (22%) for mean 24 hour glucose concentration

Patients should not consider berberine as a substitute for prescribed GLP-1 medications

Drop the used needle straight into your sharps container

Among them: Will insurers broadly cover GLP-1s for obesity? JPM thinks studies showing that these medicines can lower the risk of heart problems, kidney problems, and other health issues in people who are very overweight and have other diseases should advance payer decisions on broadly reimbursing obesity